Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600

Posted: March 16, 2025 at 2:46 am

- Company’s patented desmopressin oral solution successfully passed pivotal bioequivalence study -- Company expects to submit New Drug Application (NDA) in April 2025 -

Read more here:
Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600

Related Posts